The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
What Are The Forecasted Market Size Figures For The High Throughput Screening (HTS) Market In 2026 And 2030?
The high throughput screening (hts) market size has experienced significant expansion over recent years. Forecasts indicate it will expand from $25.26 billion in 2025 to $27.47 billion in 2026, driven by a compound annual growth rate (CAGR) of 8.7%. This historical growth can be attributed to several factors, including an escalating demand for rapid drug discovery, continuous advancements in assay technologies, increased investments in pharmaceutical R&D, a growing adoption of robotics within laboratories, and the widespread expansion of contract research organizations.
The high throughput screening (hts) market is projected to experience substantial expansion over the upcoming years. This market is anticipated to reach a valuation of $38.34 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.7%. This forecasted growth is largely driven by factors such as the incorporation of AI and machine learning into hts, the increasing prevalence of personalized medicine, a surge in investments towards biotechnology startups, the expansion of nascent markets in the Asia-Pacific region, and advancements in multiplexed and label-free assay technologies. Significant trends anticipated during this period encompass the integration of high-throughput automation, the shrinking size of screening platforms, sophisticated detection technologies, the creation of multiplexed assays, and cloud-based systems for data management.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=14116&type=smp
What Influential Factors Are Boosting The High Throughput Screening (HTS) Market Demand?
The increasing prevalence of chronic diseases is projected to propel the expansion of the high-throughput screening (HTS) market moving forward. A chronic disease is characterized as a long-term health condition or illness that persists for an extended period, typically three months or more. HTS enables the rapid evaluation of numerous chemical compounds to identify potential drug candidates targeting specific pathways or mechanisms linked to chronic conditions, which is vital for their effective long-term management. For instance, in January 2023, the National Library of Medicine, a US-based government agency, reported that the number of people in the US aged 50 and older who have at least 1 chronic condition is expected to rise to 142.66 million by 2050. Therefore, the growing incidence of chronic diseases will drive the growth of the high-throughput screening (HTS) market.
What Segment Categories Are Evaluated In The High Throughput Screening (HTS) Market Study?
The high throughput screening (hts) market covered in this report is segmented –
1) By Products And Services: Consumables And Reagents, Instruments, Software And Services
2) By Technology: Ultra-High-Throughput Screening, Cell-Based Assays, Lab-On-A-Chip, Label-Free Technology
3) By Application: Target Identification And Validation, Primary And Secondary Screening, Toxicology Assessment, Other Applications
4) By End User: Pharmaceuticals And Biotechnology Industry, Academics And Research Institute, Contract Research Organization, Other End Users
Subsegments:
1) By Consumables And Reagents: Assay Plates, Reagents And Assay Kits, Sample Preparation Kits, Detection Reagents
2) By Instruments: Automated Liquid Handlers, Plate Readers, Robotics And Automation Systems, Microfluidic Devices
3) By Software And Services: Data Analysis Software, HTS Management Software, Consulting Services, Maintenance And Support Services
What Trends Are Shaping The High Throughput Screening (HTS) Market Structure?
Leading companies operating within the high-throughput screening market are developing innovative products, such as multimode plate readers, to better cater to their customers with advanced functionalities. A multimode plate reader (MPR) is an advanced laboratory tool employed in high-throughput screening, analyzing biological and chemical specimens in microplates by integrating multiple detection modes for diverse assays on a unified platform. For example, in February 2023, PerkinElmer Inc., a US-based MedTech company, launched the EnVision Nexus system. The EnVision Nexus system stands out as the fastest and most sensitive multimode plate reader on the market, expressly designed for demanding high-throughput screening (HTS) applications to speed up drug discovery efforts. Featuring its unique technology, which includes dual detectors and optimized reagents such as proprietary HTRF and AlphaLISA, combined with the latest reagent kits, the platform offers researchers unparalleled assay flexibility, accuracy, speed, and sensitivity. Equipped with convenient walkaway options like a plate stacker for 20 or 50 plates, or full automation and integration for continuous 24/7 workflow-driven operations, the EnVision Nexus system empowers researchers to efficiently screen millions of samples with exceptional efficiency.
Who Are The Firms Contributing To The High Throughput Screening (HTS) Market Ecosystem?
Major companies operating in the high throughput screening (hts) market are Thermo Fisher Scientific Inc., AstraZeneca Plc, Danaher Corporation, Merck Group, GE HealthCare Technologies Inc., Corning Inc., Agilent Technologies Inc., Lonza Group Ltd., Charles River Laboratories International Inc, Beckman Coulter Inc., PerkinElmer Inc., Bio-Rad Laboratories, Tecan Group Ltd., Sygnature Discovery Ltd., Luminex Corporation, Hamilton Company, Crown Bioscience Inc., HighRes Biosolutions, NanoTemper Technologies GmbH, BMG LABTECH GmbH, Axxam SpA, Reprocell Inc., BioTek Instruments Inc, Aurora Biomed Inc., Cyclica Inc.
Access The Complete High Throughput Screening (HTS) Market Report:
https://www.thebusinessresearchcompany.com/report/high-throughput-screening-hts-global-market-report
Which Region Stands As The Largest Contributor To The High Throughput Screening (HTS) Market?
North America was the largest region in the high throughput screening market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the high throughput screening (hts) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access High Throughput Screening (HTS) Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/sample.aspx?id=14116&type=smp
Browse Through More Reports Similar to the Global High Throughput Screening (HTS) Market 2026, By The Business Research Company
High Throughput Screening Hts Market Report 2026
https://www.thebusinessresearchcompany.com/report/high-throughput-screening-hts-global-market-report
Carrier Screening Market Report 2026
https://www.thebusinessresearchcompany.com/report/carrier-screening-global-market-report
Herg Screening Market Report 2026
https://www.thebusinessresearchcompany.com/report/herg-screening-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model